TY - JOUR
T1 - A practical approach to uveitis screening in children with juvenile idiopathic arthritis
AU - Foeldvari, Ivan
AU - Bohn, Marcela
AU - Petrushkin, Harry
AU - Angeles Han, S
AU - Bangsgaard, Regitze
AU - Calzada-Hernández, Joan
AU - Constantin, Tamas
AU - de Boer, Joke H
AU - Díaz-Cascajosa, Jesus
AU - Edelsten, Clive
AU - Glerup, Mia
AU - Ingels, Helene
AU - Kramer, Sebastian
AU - Miserocchi, Elisabetta
AU - Nordal, Ellen
AU - Saurenmann, Rotraud K
AU - Simonini, Gabriele
AU - Solebo, Ameenat Lola
AU - Titz, Jan
AU - Anton, Jordi
N1 - © Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2024/4/4
Y1 - 2024/4/4
N2 - BACKGROUND: Juvenile idiopathic arthritis (JIA)-associated uveitis typically presents as a silent chronic anterior uveitis and can lead to blindness. Adherence to current screening guidelines is hampered by complex protocols which rely on the knowledge of specific JIA characteristics. The Multinational Interdisciplinary Working Group for Uveitis in Childhood identified the need to simplify screening to enable local eye care professionals (ECPs), who carry the main burden, to screen children with JIA appropriately and with confidence.METHODS: A consensus meeting took place in January 2023 in Barcelona, Spain, with an expert panel of 10 paediatric rheumatologists and 5 ophthalmologists with expertise in paediatric uveitis. A summary of the current evidence for JIA screening was presented. A nominal group technique was used to reach consensus.RESULTS: The need for a practical but safe approach that allows early uveitis detection was identified by the panel. Three screening recommendations were proposed and approved by the voting members. They represent a standardised approach to JIA screening taking into account the patient's age at the onset of JIA to determine the screening interval until adulthood.CONCLUSION: By removing the need for the knowledge of JIA categories, antinuclear antibody positivity or treatment status, the recommendations can be more easily implemented by local ECP, where limited information is available. It would improve the standard of care on the local level significantly. The proposed protocol is less tailored to the individual than the 'gold standard' ones it references and does not aim to substitute those where they are being used with confidence.
AB - BACKGROUND: Juvenile idiopathic arthritis (JIA)-associated uveitis typically presents as a silent chronic anterior uveitis and can lead to blindness. Adherence to current screening guidelines is hampered by complex protocols which rely on the knowledge of specific JIA characteristics. The Multinational Interdisciplinary Working Group for Uveitis in Childhood identified the need to simplify screening to enable local eye care professionals (ECPs), who carry the main burden, to screen children with JIA appropriately and with confidence.METHODS: A consensus meeting took place in January 2023 in Barcelona, Spain, with an expert panel of 10 paediatric rheumatologists and 5 ophthalmologists with expertise in paediatric uveitis. A summary of the current evidence for JIA screening was presented. A nominal group technique was used to reach consensus.RESULTS: The need for a practical but safe approach that allows early uveitis detection was identified by the panel. Three screening recommendations were proposed and approved by the voting members. They represent a standardised approach to JIA screening taking into account the patient's age at the onset of JIA to determine the screening interval until adulthood.CONCLUSION: By removing the need for the knowledge of JIA categories, antinuclear antibody positivity or treatment status, the recommendations can be more easily implemented by local ECP, where limited information is available. It would improve the standard of care on the local level significantly. The proposed protocol is less tailored to the individual than the 'gold standard' ones it references and does not aim to substitute those where they are being used with confidence.
UR - http://www.scopus.com/inward/record.url?scp=85189905666&partnerID=8YFLogxK
U2 - 10.1136/bjo-2023-324406
DO - 10.1136/bjo-2023-324406
M3 - Journal article
C2 - 38575198
SN - 0007-1161
JO - The British journal of ophthalmology
JF - The British journal of ophthalmology
M1 - bjo-2023-324406
ER -